AzTrials
AzTrials

Cerebral PalsyNCT05751135

Impact of Focal Muscle Vibration on Bio-psychosocial Outcomes in Cerebral Palsy

A study testing Focal muscle vibration, Stretching and Strengthening in people with Cerebral Palsy, run by Riphah International University at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to determine the effects of focal muscle vibration on bio-psychosocial outcomes in subjects with cerebral palsy. Mixed methods will be used and the study will be conducted in 2 phases; 1st phase is determining the effects of intervention, whereas second step is prediction of outcomes. Read more about this study

Who is it for?
Ages 3 to 15 years
Conditions the study is for
Cerebral Palsy
What is being tested?
Focal muscle vibration, Stretching and Strengthening
Could I receive a placebo?
No, everyone receives an active treatment
How many people
111 participants
Where
1 sitePakistan
Study dates
3 Mar 2023to 30 Nov 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 15 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Diagnosed spastic diplegic cerebral palsy cases with following characteristics;
  • Gross motor function classification scale levels II-IV
  • Receiving standard physical therapy care

Who cannot join

  • Severe cognitive, visual and hearing impairments.
  • History of metabolic diseases.
  • History of recent fractures.
  • Children with severe musculo-skeletal anomalies

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Al-Farabi Special Education Center For (P.H.C)

    Islamabad, 44000

Other trials in Pakistan

About this study

This study aims to determine the effects of focal muscle vibration on bio-psychosocial outcomes in subjects with cerebral palsy. Mixed methods will be used and the study will be conducted in 2 phases; 1st phase is determining the effects of intervention, whereas second step is prediction of outcomes. A qualitative gait analysis will also be done.

Read the detailed description

The literature suggests the positive effects of focal muscle vibration on various motor components of cerebral palsy. Although there is a gap regarding it's effects with perspective of bio-psychosocial model, which will be the main focus of this study. The study will look for the effects of focal muscle vibration on biological, psychological and social aspects of subjects with cerebral palsy (CP). The intervention in form of focal muscle vibration and standard physical therapy will be provided for 12 weeks and the subjects will then be followed for 4 weeks to look for retention effects, and till 24 weeks for prediction of outcomes.

Conditions
Cerebral Palsy
Being tested
Focal muscle vibration, Stretching, Strengthening, Positioning
Keywords
Cerebral palsy, Focal muscle vibration, Biopsychosocial, Functional near-infrared spectroscopy, Electroencephalography, Emotional reactivity
Medical subject headings
Cerebral Palsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Focal muscle vibrationDevice

    Focal muscle vibration will be provided by a longitudinal muscle vibrator on muscles of lower limb; hamstrings, quadriceps, illiopsoas, calf, gluteus maximus and medius. Each muscle will be targeted 3 times with 30 seconds time period and keeping 10 second interval.

  • StretchingProcedure or surgery

    Stretching of shortened lower extremity muscle

  • StrengtheningProcedure or surgery

    Strengthening exercises for weak lower extremity muscles

  • PositioningProcedure or surgery

    Positioning of participant to maintain a good body posture

Study groups in NCT05751135
Study groupRoleWhat they receive
Focal muscle vibration group 1ExperimentalFocal muscle vibration with frequency of 80 Hz will be provided 3 days along with stretching, strengthening and positioning for 8 weeks
Receives: Device: Focal muscle vibration; Procedure: Stretching; Procedure: Strengthening; Procedure: Positioning
Focal muscle vibration group 2ExperimentalFocal muscle vibration with frequency of 100 Hz will be provided 3 days a week along with stretching, strengthening and positioning for 8 weeks.
Receives: Device: Focal muscle vibration; Procedure: Stretching; Procedure: Strengthening; Procedure: Positioning
Control groupActive comparatorStretching, strengthening and positioning in 3 sessions a week for 8 weeks
Receives: Procedure: Stretching; Procedure: Strengthening; Procedure: Positioning

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Functional near-infrared spectroscopy (fNIRS)

    Functional near-infrared spectroscopy (fNIRS) is an optical imaging tool for noninvasive, continuous monitoring of regional blood flow and tissue oxygenation. It can measure two hemodynamic parameters, both deoxyhemoglobin (HHb) and oxyhemoglobin (HbO2), at the same time. It reflects changes in regional blood flow to areas of the brain involved in processing functional tasks.

    Measured: Baseline

  2. Functional near-infrared spectroscopy (fNIRS)

    Functional near-infrared spectroscopy (fNIRS) is an optical imaging tool for noninvasive, continuous monitoring of regional blood flow and tissue oxygenation. It can measure two hemodynamic parameters, both deoxyhemoglobin (HHb) and oxyhemoglobin (HbO2), at the same time. It reflects changes in regional blood flow to areas of the brain involved in processing functional tasks.

    Measured: After 4 weeks

  3. Functional near-infrared spectroscopy (fNIRS)

    Functional near-infrared spectroscopy (fNIRS) is an optical imaging tool for noninvasive, continuous monitoring of regional blood flow and tissue oxygenation. It can measure two hemodynamic parameters, both deoxyhemoglobin (HHb) and oxyhemoglobin (HbO2), at the same time. It reflects changes in regional blood flow to areas of the brain involved in processing functional tasks.

    Measured: After 8 weeks

  4. Electroencephalogram (EEG)

    The EEG will be recorded from 40-scalp electrodes using the extended 10-20 system montage (Quick-Cap International). The participant will be seated comfortably in a chair with eyes closed throughout the entire recording. We will record a period of resting whole head EEG. We will use standardized low-resolution brain electromagnetic tomography (sLORETA) for the resting EEG to calculate potential changes (Spatio-spectral Analysis) in brain activity and communication post the chiropractic care intervention.

    Measured: Baseline

  5. Electroencephalogram (EEG)

    The EEG will be recorded from 40-scalp electrodes using the extended 10-20 system montage (Quick-Cap International). The participant will be seated comfortably in a chair with eyes closed throughout the entire recording. We will record a period of resting whole head EEG. We will use standardized low-resolution brain electromagnetic tomography (sLORETA) for the resting EEG to calculate potential changes (Spatio-spectral Analysis) in brain activity and communication post the chiropractic care intervention.

    Measured: After 4 weeks

  6. Electroencephalogram (EEG)

    The EEG will be recorded from 40-scalp electrodes using the extended 10-20 system montage (Quick-Cap International). The participant will be seated comfortably in a chair with eyes closed throughout the entire recording. We will record a period of resting whole head EEG. We will use standardized low-resolution brain electromagnetic tomography (sLORETA) for the resting EEG to calculate potential changes (Spatio-spectral Analysis) in brain activity and communication post the chiropractic care intervention.

    Measured: After 8 weeks

  7. Gross Motor Function Measure

    Gross motor function measure is a standard instrument which measures the change in motor function with time in CP subjects. It assess the amount of motor task a child can perform. an 88 point tool with scoring of 0-3 for each item, with 0 = doesn't initate activity to 3= complete the activity

    Measured: Baseline

  8. Gross Motor Function Measure

    Gross motor function measure is a standard instrument which measures the change in motor function with time in CP subjects. It assess the amount of motor task a child can perform. an 88 point tool with scoring of 0-3 for each item, with 0 = doesn't initate activity to 3= complete the activity

    Measured: After 4 weeks

  9. Gross Motor Function Measure

    Gross motor function measure is a standard instrument which measures the change in motor function with time in CP subjects. It assess the amount of motor task a child can perform. an 88 point tool with scoring of 0-3 for each item, with 0 = doesn't initate activity to 3= complete the activity

    Measured: After 8 weeks

  10. Gross Motor Function Measure

    Gross motor function measure is a standard instrument which measures the change in motor function with time in CP subjects. It assess the amount of motor task a child can perform. an 88 point tool with scoring of 0-3 for each item, with 0 = doesn't initate activity to 3= complete the activity

    Measured: After 12 weeks

  11. Modified Ashworth scale

    It is standard tool for measuring the spasticity with scoring 0-5, 0=no increase in muscle tone to 5=rigid in flexion and extension

    Measured: Baseline

  12. Modified Ashworth scale

    It is standard tool for measuring the spasticity with scoring 0-5, 0=no increase in muscle tone to 5=rigid in flexion and extension

    Measured: After 4 weeks

  13. Modified Ashworth scale

    It is standard tool for measuring the spasticity with scoring 0-5, 0=no increase in muscle tone to 5=rigid in flexion and extension

    Measured: After 8 weeks

  14. Modified Ashworth scale

    It is standard tool for measuring the spasticity with scoring 0-5, 0=no increase in muscle tone to 5=rigid in flexion and extension

    Measured: After 12 weeks

  15. Child Behavior Checklist (CBCL)

    The Child Behavior Checklist (CBCL) is a checklist parents complete to detect emotional and behavioral problems in children and adolescents. There are 2 checklists; 1 for ages 1.5 to 5 years and other for 6 to 18 years of age.

    Measured: Baseline

  16. Child Behavior Checklist (CBCL)

    The Child Behavior Checklist (CBCL) is a checklist parents complete to detect emotional and behavioral problems in children and adolescents. There are 2 checklists; 1 for ages 1.5 to 5 years and other for 6 to 18 years of age.

    Measured: After 4 weeks

  17. Child Behavior Checklist (CBCL)

    The Child Behavior Checklist (CBCL) is a checklist parents complete to detect emotional and behavioral problems in children and adolescents. There are 2 checklists; 1 for ages 1.5 to 5 years and other for 6 to 18 years of age.

    Measured: After 8 weeks

  18. Child Behavior Checklist (CBCL)

    The Child Behavior Checklist (CBCL) is a checklist parents complete to detect emotional and behavioral problems in children and adolescents. There are 2 checklists; 1 for ages 1.5 to 5 years and other for 6 to 18 years of age.

    Measured: After 12 weeks

  19. Social support questionnaire

    A 6 item questionnaire designed to measure perceptions of social support and satisfaction with that social support

    Measured: Baseline

  20. Social support questionnaire

    A 6 item questionnaire designed to measure perceptions of social support and satisfaction with that social support

    Measured: After 4 weeks

  21. Social support questionnaire

    A 6 item questionnaire designed to measure perceptions of social support and satisfaction with that social support

    Measured: After 8 weeks

  22. Social support questionnaire

    A 6 item questionnaire designed to measure perceptions of social support and satisfaction with that social support

    Measured: After 12 weeks

  23. Self perception profile

    Targeting the self-perception this tool is used to determine global psychosocial function and encompasses major domains; scholastic, social, athletic competence, physical appearance, behavioral conduct and global self-worth. There are 6 domains with 36 items in total with in each item is scored on a four-point scale from 1 to 4.

    Measured: Baseline

  24. Self perception profile

    Targeting the self-perception this tool is used to determine global psychosocial function and encompasses major domains; scholastic, social, athletic competence, physical appearance, behavioral conduct and global self-worth. There are 6 domains with 36 items in total with in each item is scored on a four-point scale from 1 to 4.

    Measured: After 4 weeks

  25. Self perception profile

    Targeting the self-perception this tool is used to determine global psychosocial function and encompasses major domains; scholastic, social, athletic competence, physical appearance, behavioral conduct and global self-worth. There are 6 domains with 36 items in total with in each item is scored on a four-point scale from 1 to 4.

    Measured: After 8 weeks

  26. Self perception profile

    Targeting the self-perception this tool is used to determine global psychosocial function and encompasses major domains; scholastic, social, athletic competence, physical appearance, behavioral conduct and global self-worth. There are 6 domains with 36 items in total with in each item is scored on a four-point scale from 1 to 4.

    Measured: After 12 weeks

  27. Perth Emotional Reactivity Scale (PERS-S)

    The Perth Emotional Reactivity Scale (PERS-S) is 18 item self-report measure of trait levels of emotional reactivity, derived from original version of 30 item.

    Measured: Baseline

  28. Perth Emotional Reactivity Scale (PERS-S)

    The Perth Emotional Reactivity Scale (PERS-S) is 18 item self-report measure of trait levels of emotional reactivity, derived from original version of 30 item.

    Measured: After 4 weeks

  29. Perth Emotional Reactivity Scale (PERS-S)

    The Perth Emotional Reactivity Scale (PERS-S) is 18 item self-report measure of trait levels of emotional reactivity, derived from original version of 30 item.

    Measured: After 8 weeks

  30. Perth Emotional Reactivity Scale (PERS-S)

    The Perth Emotional Reactivity Scale (PERS-S) is 18 item self-report measure of trait levels of emotional reactivity, derived from original version of 30 item.

    Measured: After 12 weeks

  31. Modified Caregiver Strain Index (MCSI)

    The Modified Caregiver Strain Index (MCSI) is used to screen for caregiver strain with long-term family caregivers. It is short and quick with 13 questions, which measures strain related to care provision.

    Measured: Baseline

  32. Modified Caregiver Strain Index (MCSI)

    The Modified Caregiver Strain Index (MCSI) is used to screen for caregiver strain with long-term family caregivers. It is short and quick with 13 questions, which measures strain related to care provision.

    Measured: After 4 weeks

  33. Modified Caregiver Strain Index (MCSI)

    The Modified Caregiver Strain Index (MCSI) is used to screen for caregiver strain with long-term family caregivers. It is short and quick with 13 questions, which measures strain related to care provision.

    Measured: After 8 weeks

  34. Modified Caregiver Strain Index (MCSI)

    The Modified Caregiver Strain Index (MCSI) is used to screen for caregiver strain with long-term family caregivers. It is short and quick with 13 questions, which measures strain related to care provision.

    Measured: After 12 weeks

  35. Electromyography (EMG)

    EMG will identify any changes in co-contraction between the muscles; quadriceps and hamstrings.

    Measured: Baseline

  36. Electromyography (EMG)

    EMG will identify any changes in co-contraction between the muscles; quadriceps and hamstrings.

    Measured: After 4 weeks

  37. Electromyography (EMG)

    EMG will identify any changes in co-contraction between the muscles; quadriceps and hamstrings.

    Measured: After 8 weeks

  38. Trunk control measurement scale (TCMS)

    Trunk control measurement scale will determine the level of trunk control in a child with CP. It comprises of static and dynamic sitting balance along with reaching activities which determine the equilibrium. The maximum score is 58, the higher the scores indicate better trunk control.

    Measured: Baseline

  39. Trunk control measurement scale (TCMS)

    Trunk control measurement scale will determine the level of trunk control in a child with CP. It comprises of static and dynamic sitting balance along with reaching activities which determine the equilibrium. The maximum score is 58, the higher the scores indicate better trunk control.

    Measured: After 4 weeks

  40. Trunk control measurement scale (TCMS)

    Trunk control measurement scale will determine the level of trunk control in a child with CP. It comprises of static and dynamic sitting balance along with reaching activities which determine the equilibrium. The maximum score is 58, the higher the scores indicate better trunk control.

    Measured: After 8 weeks

  41. Trunk control measurement scale (TCMS)

    Trunk control measurement scale will determine the level of trunk control in a child with CP. It comprises of static and dynamic sitting balance along with reaching activities which determine the equilibrium. The maximum score is 58, the higher the scores indicate better trunk control.

    Measured: After 12 weeks

  42. Pediatric Balance Scale (PBS)

    Pediatric Balance Scale will determine the level of balance and postural control in a child with CP. The maximum score is 56 and higher scores indicate better level of balance while score closer to zero indicate impaired balance.

    Measured: Baseline

  43. Pediatric Balance Scale (PBS)

    Pediatric Balance Scale will determine the level of balance and postural control in a child with CP. The maximum score is 56 and higher scores indicate better level of balance while score closer to zero indicate impaired balance.

    Measured: After 4 weeks

  44. Pediatric Balance Scale (PBS)

    Pediatric Balance Scale will determine the level of balance and postural control in a child with CP. The maximum score is 56 and higher scores indicate better level of balance while score closer to zero indicate impaired balance.

    Measured: After 8 weeks

  45. Pediatric Balance Scale (PBS)

    Pediatric Balance Scale will determine the level of balance and postural control in a child with CP. The maximum score is 56 and higher scores indicate better level of balance, while score closer to zero indicate impaired balance.

    Measured: After 12 weeks

  46. Dynamometer

    The dynamometer will be used to determine the strength in lower limb muscles; quadriceps, hamstrings, adductors and abductors of the CP subjects

    Measured: Bassline

  47. Dynamometer

    The dynamometer will be used to determine the strength in lower limb muscles; quadriceps, hamstrings, adductors and abductors of the CP subjects

    Measured: After 4 weeks

  48. Dynamometer

    The dynamometer will be used to determine the strength in lower limb muscles; quadriceps, hamstrings, adductors and abductors of the CP subjects

    Measured: After 8 weeks

  49. Dynamometer

    The dynamometer will be used to determine the strength in lower limb muscles; quadriceps, hamstrings, adductors and abductors of the CP subjects

    Measured: After 12 weeks

  50. Cerebral Palsy Quality of Life (CPQOL)

    Cerebral Palsy Quality of Life is tool to access the quality of life of children with CP it incorporates parental impact and family functioning along with concepts of illness, functional status, mental health, and comfort. Items are transformed to range of 0-100, the algebraic mean of item values is computer for each domain

    Measured: Baseline

  51. Cerebral Palsy Quality of Life (CPQOL)

    Cerebral Palsy Quality of Life is tool to access the quality of life of children with CP it incorporates parental impact and family functioning along with concepts of illness, functional status, mental health, and comfort. Items are transformed to range of 0-100, the algebraic mean of item values is computer for each domain

    Measured: After 4 weeks

  52. Cerebral Palsy Quality of Life (CPQOL)

    Cerebral Palsy Quality of Life is tool to access the quality of life of children with CP it incorporates parental impact and family functioning along with concepts of illness, functional status, mental health, and comfort. Items are transformed to range of 0-100, the algebraic mean of item values is computer for each domain

    Measured: After 8 weeks

  53. Cerebral Palsy Quality of Life (CPQOL)

    Cerebral Palsy Quality of Life is tool to access the quality of life of children with CP it incorporates parental impact and family functioning along with concepts of illness, functional status, mental health, and comfort. Items are transformed to range of 0-100, the algebraic mean of item values is computer for each domain

    Measured: After 12 weeks

  54. Edinburgh Visual Gait Assessment Score

    Edinburgh Visual Gait Assessment (EVGA) is an assessment tool which qualitatively asses various parameters of gait via video recordings. It uses lateral and anterior views of gait to identify the quality of gait patterns and movements.

    Measured: Baseline

  55. Edinburgh Visual Gait Assessment Score

    Edinburgh Visual Gait Assessment (EVGA ) is an assessment tool which qualitatively asses various parameters of gait via video recordings. It uses lateral and anterior views of gait to identify the quality of gait patterns and movements.

    Measured: After 4 weeks

  56. Edinburgh Visual Gait Assessment Score

    Edinburgh Visual Gait Assessment Score (EVGA) is an assessment tool which qualitatively asses various parameters of gait via video recordings. It uses lateral and anterior views of gait to identify the quality of gait patterns and movements.

    Measured: After 8 weeks

  57. Edinburgh Visual Gait Assessment Score

    Edinburgh Visual Gait Assessment Score (EVGA) is an assessment tool which qualitatively asses various parameters of gait via video recordings. It uses lateral and anterior views of gait to identify the quality of gait patterns and movements.

    Measured: After 12 weeks

  58. Child friendly Depression Anxiety Stress Scale 21 (DASS-21)

    A 21 item scale derive from DASS 42 to access the depression, anxiety and stress among children

    Measured: Baseline

  59. Child friendly Depression Anxiety Stress Scale 21 (DASS-21)

    A 21 item scale derive from DASS 42 to access the depression, anxiety and stress among children

    Measured: After 4 weeks

  60. Child friendly Depression Anxiety Stress Scale 21 (DASS-21)

    A 21 item scale derive from DASS 42 to access the depression, anxiety and stress among children

    Measured: After 8 weeks

  61. Child friendly Depression Anxiety Stress Scale 21 (DASS-21)

    A 21 item scale derive from DASS 42 to access the depression, anxiety and stress among children

    Measured: After 12 weeks

  62. Immune Response Questionnaire (IRQ)

    The Immune Function Questionnaire (IFQ) consists of 15 items that assess the frequency of various symptoms associated with poor immune function. There are 19 symptom items included on the questionnaire as signs of weakened immune system functioning: headaches, sore throat, eye infection, sinusitis, runny nose, flu, coughing, cold sores, boils, mild fever, pneumonia, bronchitis, warts/verrucas, sepsis, ear infection, diarrhea, meningitis, sudden high fever, and prolonged healing injuries. The IFQ score has been found to positively correlate with the number of visits to a General Medical Practitioner. Assessment of participants will be repeated after 6 weeks of intervention. Calculate the sum score of the 7 IFQ items. To obtain the final IFQ score, translate the "raw" IFQ scores as follows: Interpretation: 0 = very poor, 10 excellent perceived immune status

    Measured: Baseline

  63. Immune Response Questionnaire (IRQ)

    The Immune Function Questionnaire (IFQ) consists of 15 items that assess the frequency of various symptoms associated with poor immune function. There are 19 symptom items included on the questionnaire as signs of weakened immune system functioning: headaches, sore throat, eye infection, sinusitis, runny nose, flu, coughing, cold sores, boils, mild fever, pneumonia, bronchitis, warts/verrucas, sepsis, ear infection, diarrhea, meningitis, sudden high fever, and prolonged healing injuries. The IFQ score has been found to positively correlate with the number of visits to a General Medical Practitioner. Assessment of participants will be repeated after 6 weeks of intervention. Calculate the sum score of the 7 IFQ items. To obtain the final IFQ score, translate the "raw" IFQ scores as follows: Interpretation: 0 = very poor, 10 excellent perceived immune status

    Measured: After 4 weeks

  64. Immune Response Questionnaire (IRQ)

    The Immune Function Questionnaire (IFQ) consists of 15 items that assess the frequency of various symptoms associated with poor immune function. There are 19 symptom items included on the questionnaire as signs of weakened immune system functioning: headaches, sore throat, eye infection, sinusitis, runny nose, flu, coughing, cold sores, boils, mild fever, pneumonia, bronchitis, warts/verrucas, sepsis, ear infection, diarrhea, meningitis, sudden high fever, and prolonged healing injuries. The IFQ score has been found to positively correlate with the number of visits to a General Medical Practitioner. Assessment of participants will be repeated after 6 weeks of intervention. Calculate the sum score of the 7 IFQ items. To obtain the final IFQ score, translate the "raw" IFQ scores as follows: Interpretation: 0 = very poor, 10 excellent perceived immune status

    Measured: After 8 weeks

  65. Immune Response Questionnaire (IRQ)

    The Immune Function Questionnaire (IFQ) consists of 15 items that assess the frequency of various symptoms associated with poor immune function. There are 19 symptom items included on the questionnaire as signs of weakened immune system functioning: headaches, sore throat, eye infection, sinusitis, runny nose, flu, coughing, cold sores, boils, mild fever, pneumonia, bronchitis, warts/verrucas, sepsis, ear infection, diarrhea, meningitis, sudden high fever, and prolonged healing injuries. The IFQ score has been found to positively correlate with the number of visits to a General Medical Practitioner. Assessment of participants will be repeated after 6 weeks of intervention. Calculate the sum score of the 7 IFQ items. To obtain the final IFQ score, translate the "raw" IFQ scores as follows: Interpretation: 0 = very poor, 10 excellent perceived immune status

    Measured: After 12 weeks

  66. Reaction Time

    Reaction Time provides assessments of motor and mental response speeds and measures of movement time, reaction time, response accuracy, and impulsivity.

    Outcome measures are divided into reaction time and movement time for both the simple and five-choice variants.

    It's a six-minute test that covers latency (response speed), correct responses and errors of commission and omission.

    More accurate reaction in less time inclines toward good reaction time

    Measured: Baseline

  67. Reaction Time

    Reaction Time provides assessments of motor and mental response speeds and measures of movement time, reaction time, response accuracy, and impulsivity.

    Outcome measures are divided into reaction time and movement time for both the simple and five-choice variants.

    It's a six-minute test that covers latency (response speed), correct responses and errors of commission and omission.

    More accurate reaction in less time inclines toward good reaction time

    Measured: After 4 weeks

  68. Reaction Time

    Reaction Time provides assessments of motor and mental response speeds and measures of movement time, reaction time, response accuracy, and impulsivity.

    Outcome measures are divided into reaction time and movement time for both the simple and five-choice variants.

    It's a six-minute test that covers latency (response speed), correct responses and errors of commission and omission.

    More accurate reaction in less time inclines toward good reaction time

    Measured: After 8 weeks

  69. Reaction Time

    Reaction Time provides assessments of motor and mental response speeds and measures of movement time, reaction time, response accuracy, and impulsivity.

    Outcome measures are divided into reaction time and movement time for both the simple and five-choice variants.

    It's a six-minute test that covers latency (response speed), correct responses and errors of commission and omission.

    More accurate reaction in less time inclines toward good reaction time

    Measured: After 12 weeks

  70. Heart rate variability (HRV)

    Heart rate variability (HRV) will be used as an objective assessment of psychological health and stress for the participants. High HRV is a marker of an adaptable, responsive nervous system that can detect sensory stimuli and appropriately increase or decrease the heart rate based on the needs of the individual. Low HRV and low parasympathetic activity is associated with chronic pain states, poor cardiovascular health and mood disorders. Heart Rate will be monitored throughout the session. Assessment of participants will be continued throughout the intervention.

    Measured: Baseline

  71. Heart rate variability (HRV)

    Heart rate variability (HRV) will be used as an objective assessment of psychological health and stress for the participants. High HRV is a marker of an adaptable, responsive nervous system that can detect sensory stimuli and appropriately increase or decrease the heart rate based on the needs of the individual. Low HRV and low parasympathetic activity is associated with chronic pain states, poor cardiovascular health and mood disorders. Heart Rate will be monitored throughout the session. Assessment of participants will be continued throughout the intervention

    Measured: After 4 weeks

  72. Heart rate variability (HRV)

    Heart rate variability (HRV) will be used as an objective assessment of psychological health and stress for the participants. High HRV is a marker of an adaptable, responsive nervous system that can detect sensory stimuli and appropriately increase or decrease the heart rate based on the needs of the individual. Low HRV and low parasympathetic activity is associated with chronic pain states, poor cardiovascular health and mood disorders. Heart Rate will be monitored throughout the session. Assessment of participants will be continued throughout the intervention

    Measured: After 8 weeks

  73. Heart rate variability (HRV)

    Heart rate variability (HRV) will be used as an objective assessment of psychological health and stress for the participants. High HRV is a marker of an adaptable, responsive nervous system that can detect sensory stimuli and appropriately increase or decrease the heart rate based on the needs of the individual. Low HRV and low parasympathetic activity is associated with chronic pain states, poor cardiovascular health and mood disorders. Heart Rate will be monitored throughout the session. Assessment of participants will be continued throughout the intervention

    Measured: After 12 weeks

  74. Manual Muscle Testing (MMT)

    Manual muscle testing will be used to determine the strength of lower limb muscles. It has scores from 0 to 5, with 5 being the movement against maximum resistance and 0 being no contraction.

    Measured: Baseline

  75. Manual Muscle Testing (MMT)

    Manual muscle testing will be used to determine the strength of lower limb muscles. It has scores from 0 to 5, with 5 being the movement against maximum resistance and 0 being no contraction.

    Measured: After 4 weeks

  76. Manual Muscle Testing (MMT)

    Manual muscle testing will be used to determine the strength of lower limb muscles. It has scores from 0 to 5, with 5 being the movement against maximum resistance and 0 being no contraction.

    Measured: After 8 weeks

  77. Manual Muscle Testing (MMT)

    Manual muscle testing will be used to determine the strength of lower limb muscles. It has scores from 0 to 5, with 5 being the movement against maximum resistance and 0 being no contraction.

    Measured: After 12 weeks

  78. Semi structured interview

    A semi-structured interview will be conducted with parents/ caregivers of CP subjects focusing on the feedback about treatment protocols and social, psychological and physical status and needs, and any observed change in needs or status

    Measured: After 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Mar 2023
  2. Study start3 Mar 2023
  3. Primary completion30 Sep 2023
  4. Study completion30 Nov 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
3 parallel group mixed methods
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
111 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05751135
Sponsor's protocol ID
REC-01289 KiranKhushnood
Status last verified
Jan 2024
First submitted
20 Feb 2023
Last updated
30 Jan 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Ashfaque M, Khushnood K, Naik GR, Niazi IK, Amjad I, Pujari AN. Eight weeks of focal muscle vibration shows improvements in muscle co-ordination and co-contraction in cerebral palsy children: a randomized control trial. J Neuroeng Rehabil. 2026 Jul 30;23(1):250. doi: 10.1186/s12984-026-02066-8.

    PubMed 42642763

Questions about this trial

What is this clinical trial studying?

A study testing Focal muscle vibration, Stretching and Strengthening in people with Cerebral Palsy, run by Riphah International University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Functional near-infrared spectroscopy (fNIRS) (time frame: Baseline). The study lists 78 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05751135, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jan 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in